Earnings History Data for Intra-Cellular Therapies Inc. (ITCI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	PM		ITCI	Intra-Cellular Therapies Inc.	8,120	-0.25	-0.18	-0.25	Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M [10/30/2024 7:33 AM]	85.80	9.05 (11.79%)	79.24	2.49 (3.24%)	45.50 - 88.00	2,236,694	450,000	12,898
Intra-Cellular Therapies Q3 2024 Earnings Preview [10/29/2024 3:39 PM] Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M [10/30/2024 7:33 AM] Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens [10/30/2024 11:13 AM] What To Expect From Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings [Oct-29-24 09:05AM] Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance [2024-10-30 07:30AM]
07-08-2024	PM		ITCI	Intra-Cellular Therapies Inc.	8,160	-0.16	-0.18	-0.45	Intra-Cellular Therapies GAAP EPS of -$0.16 beats by $0.05, revenue of $161.3M beats by $3.42M [8/7/2024 7:32 AM]	73.71	-4.46 (-5.71%)	78.03	-0.14 (-0.18%)	45.50 - 84.89	1,803,422	740,000	5,684
Intra-Cellular Therapies Q2 2024 Earnings Preview [8/6/2024 1:24 PM] Intra-Cellular Therapies GAAP EPS of -$0.16 beats by $0.05, revenue of $161.3M beats by $3.42M [8/7/2024 7:32 AM] Intra-Cellular Therapies names Sanjeev Narula as CFO [8/7/2024 7:59 AM]
07-05-2024	PM		ITCI	IntraCellular Therapies	6,809	-0.16	-0.31	0.00	Intra-Cellular Therapies beats Q1 estimates [5/7/2024 7:33 AM]	71.23	0.22 (0.31%)	71.30	0.29 (0.41%)	45.50 - 84.89	902,340	780,000	1,301
Intra-Cellular Therapies beats Q1 estimates [5/7/2024 7:33 AM] Intra-Cellular Therapies Q1 2024 Earnings Preview [5/6/2024 10:37 AM]
22-02-2024	PM		ITCI	Intra-Cellular Therapies Inc.	7,280	-0.30	-0.44	-0.45	Intra-Cellular Therapies GAAP EPS of -$0.30 beats by $0.15, revenue of $132M misses by $3.67M [2/22/2024 7:35 AM]	72.00	-1.28 (-1.74%)	74.25	0.97 (1.32%)	42.01 - 76.11	1,706,067	870,000	2,358
Intra-Cellular Therapies Q4 2023 Earnings Preview [2/21/2024 11:36 AM] Intra-Cellular Therapies GAAP EPS of -$0.30 beats by $0.15, revenue of $132M misses by $3.67M [2/22/2024 7:35 AM]
02-11-2023	PM		ITCI	Intra-Cellular Therapies Inc.	4,780	-0.25	-0.57	-0.57	Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34, revenue of $126.17M beats by $6.94M [11/2/2023 7:45 AM]	52.38	1.51 (2.97%)	52.38	0.0 (0.00%)	42.01 - 67.05	2,084,606	1,180,000	319,872
Intra-Cellular Therapies Q3 2023 Earnings Preview [11/1/2023 1:12 PM] Intra-Cellular Therapies GAAP EPS of -$0.25 beats by $0.34, revenue of $126.17M beats by $6.94M [11/2/2023 7:45 AM]
03-08-2023	PM		ITCI	Intra-Cellular Therapies Inc.	5,840	-0.45	-0.62	-0.92	Intra-Cellular Therapies beats top and bottom line estimates, gives FY guidance [8/3/2023 7:35 AM]	58.89	-1.98 (-3.25%)	58.89	0.0 (0.00%)	42.01 - 67.05	1,453,904	550,000	20,797
Intra-Cellular Therapies Q2 2023 Earnings Preview [8/2/2023 2:28 PM] Intra-Cellular Therapies beats top and bottom line estimates, gives FY guidance [8/3/2023 7:35 AM]
04-05-2023	PM	7:30 AM ET (May 4)	ITCI	Intra-Cellular Therapies Inc.	6,030	-0.46	-0.63	-0.78	Intra-Cellular Therapies GAAP EPS of -$0.46 beats by $0.16, revenue of $95.31M beats by $2.9M [5/4/2023 7:37 AM]	62.12	-1.13 (-1.79%)	62.40	-0.85 (-1.34%)	42.01 - 66.09	710,306	990,000	472
Intra-Cellular Therapies Q1 2023 Earnings Preview [5/3/2023 1:39 PM] Intra-Cellular Therapies GAAP EPS of -$0.46 beats by $0.16, revenue of $95.31M beats by $2.9M [5/4/2023 7:37 AM]
01-03-2023	PM	7:30 AM ET (Mar 1)	ITCI	Intra-Cellular Therapies Inc.	4,380	-0.45	-0.62	-1.05	Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M [3/1/2023 7:33 AM]	49.25	0.22 (0.45%)	52.25	3.22 (6.57%)	42.42 - 66.00	1,471,645	910,000	4,466
Intra-Cellular Therapies Q4 2022 Earnings Preview [2/28/2023 1:07 PM] Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M [3/1/2023 7:33 AM]
03-11-2022	PM	7:30 AM ET (Nov 3)	ITCI	Intra-Cellular Therapies Inc.	4,340	-0.57	-0.86	-0.95	Intra-Cellular Therapies GAAP EPS of -$0.57 beats by $0.25, revenue of $71.9M beats by $5.9M [11/3/2022 7:42 AM]	51.86	6.03 (13.16%)	46.07	0.24 (0.52%)	34.43 - 66.00	1,732,585	730,000	860
Intra-Cellular Therapies Q3 2022 Earnings Preview [11/2/2022 1:39 PM] Intra-Cellular Therapies GAAP EPS of -$0.57 beats by $0.25, revenue of $71.9M beats by $5.9M [11/3/2022 7:42 AM] Intra-Cellular stock surges 11% as bipolar depression drug sales skyrockets in Q3 [11/3/2022 11:44 AM] Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-03-22 07:30AM]
09-08-2022	PM	7:30 AM ET (Aug 9)	ITCI	Intra-Cellular Therapies Inc.	5,250	-0.92	-0.79	-0.85	Intra-Cellular Therapies GAAP EPS of -$0.92 misses by $0.15, revenue of $55.6M beats by $6.98M [8/9/2022 7:34 AM]	56.34	-2.51 (-4.27%)	59.55	0.70 (1.19%)	28.40 - 66.00	796,652	800,000	495
Intra-Cellular Therapies Q2 2022 Earnings Preview [8/8/2022 2:22 PM] Intra-Cellular Therapies GAAP EPS of -$0.92 misses by $0.15, revenue of $55.6M beats by $6.98M [8/9/2022 7:34 AM]
10-05-2022	PM	7:30 AM ET (May 10)	ITCI	Intra-Cellular Therapies Inc.	4,360	-0.78	-0.93	-0.65	Intra-Cellular Therapies GAAP EPS of -$0.78 beats by $0.15, revenue of $35M beats by $1.48M [5/10/2022 7:36 AM]	52.74	9.74 (22.66%)	46.66	3.66 (8.51%)	28.40 - 66.00	2,069,808	936,691	651
Intra-Cellular Therapies Q1 2022 Earnings Preview [5/9/2022 12:31 PM] Intra-Cellular Therapies GAAP EPS of -$0.78 beats by $0.15, revenue of $35M beats by $1.48M [5/10/2022 7:36 AM] Intra-Cellular rises 18% as robust demand for bipolar depression drug drives Q1 beat [5/10/2022 1:12 PM] Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates [May-09-22 05:15PM] Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-10-22 07:30AM] Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates [May-10-22 08:45AM]
01-03-2022	PM	7:30 AM ET (Mar 1)	ITCI	Intra-Cellular Therapies Inc.	5,110	-1.05	-1.05	-0.76	Intra-Cellular Therapies GAAP EPS of -$1.05 misses by $0.05, revenue of $25.67M beats by $0.74M [3/1/2022 7:35 AM]	56.20	0.72 (1.30%)	55.45	-0.03 (-0.05%)	28.40 - 58.88	1,074,620	1,140,000	102
Intra-Cellular Therapies GAAP EPS of -$1.05 misses by $0.05, revenue of $25.67M beats by $0.74M [3/1/2022 7:35 AM] Why Earnings Season Could Be Great for Intra-Cellular Therapies (ITCI) [Feb-28-22 08:38AM] Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 07:55AM] Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update [Mar-01-22 07:30AM] Intra-Cellular Therapies (ITCI) Reports Q4 Loss, Tops Revenue Estimates [Mar-01-22 08:55AM]
09-11-2021	PM	7:30 AM ET (Nov 9)	ITCI	Intra-Cellular Therapies Inc.	3,740	-0.95	-0.89	-0.79	Intra-Cellular Therapies EPS misses by $0.04, beats on revenue [11/9/2021 7:37 AM]	44.41	0.19 (0.43%)	44.22	0.0 (0.00%)	23.38 - 47.02	395,531	510,000	143,789
Intra-Cellular Therapies Q3 2021 Earnings Preview [11/8/2021 12:27 PM] Intra-Cellular Therapies EPS misses by $0.04, beats on revenue [11/9/2021 7:37 AM] Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-09-21 07:30AM] Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 08:45AM] Intra-Cellular Therapies inc (ITCI) Q3 2021 Earnings Call Transcript [Nov-09-21 02:00PM]
09-08-2021	PM	7:30 AM ET (Aug 9)	ITCI	Intra-Cellular Therapies Inc.	2,780	-0.85	-0.79	-0.96	Intra-Cellular Therapies EPS misses by $0.04, beats on revenue [8/9/2021 7:32 AM]	31.73	-1.76 (-5.26%)	33.49	0.0 (0.00%)	17.26 - 44.80	886,253	380,000	6,773
Intra-Cellular Therapies EPS misses by $0.04, beats on revenue [8/9/2021 7:32 AM] Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-09-21 07:30AM] Intra-Cellular Therapies (ITCI) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-21 09:05AM] Intra-Cellular Therapies inc (ITCI) Q2 2021 Earnings Call Transcript [Aug-09-21 06:00PM]
10-05-2021	PM	7:30 AM ET (May 10)	ITCI	Intra-Cellular Therapies Inc.	2,710	-0.65	-0.81	-0.73	Intra-Cellular Therapies EPS beats by $0.14, misses on revenue [5/10/2021 7:32 AM]	35.97	0.94 (2.68%)	35.03	0.0 (0.00%)	17.26 - 40.01	690,873	520,000	86,221
Intra-Cellular Therapies EPS beats by $0.14, misses on revenue [5/10/2021 7:32 AM] Intra-Cellular Therapies, Inc. to Host Earnings Call [May-10-21 06:45AM] Intra-Cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-10-21 07:30AM] Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates [May-10-21 08:45AM] Intra-Cellular Therapies Inc (ITCI) Q1 2021 Earnings Call Transcript [May-10-21 03:00PM]
25-02-2021	PM	7:30 AM ET (Feb 25)	ITCI	Intra-Cellular Therapies Inc.	2,960	-0.76	-0.85	-0.74	Intra-Cellular Therapies EPS beats by $0.09, beats on revenue [2/25/2021 7:33 AM]	35.69	-2.15 (-5.68%)	37.84	0.0 (0.00%)	10.94 - 40.01	590,990	703,382	8,254
Intra-Cellular Therapies EPS beats by $0.09, beats on revenue [2/25/2021 7:33 AM] Intra-Cellular expands pipeline with a new therapy targeting dementia [2/24/2021 2:27 PM] Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update [Feb-25-21 07:30AM] Intra-Cellular Therapies, Inc. to Host Earnings Call [Feb-25-21 06:30AM] Intra-Cellular Therapies Discloses New Drug Candidate For Dementia Related Episodes [Feb-24-21 10:42AM] Intra-Cellular Therapies Announces Expansion of its Pipeline with the Introduction of a New Molecular Entity, ITI-1284 [Feb-24-21 07:30AM]
09-11-2020	PM	7:30 AM ET (Nov 9)	ITCI	Intra-Cellular Therapies Inc.	1,960	-0.79	-0.96	-0.63	Intra-Cellular Therapies EPS beats by $0.20, beats on revenue [11/9/2020 7:33 AM]	26.58	2.12 (8.67%)	25.00	0.54 (2.21%)	8.51 - 43.56	1,493,302	789,248	6,899

10-08-2020	PM	7:30 AM ET (Aug 10)	ITCI	Intra-Cellular Therapies Inc.	1,370	-0.96	-0.94	-0.68	Intra-Cellular Therapies EPS misses by $0.06, misses on revenue [8/10/2020 7:31 AM]	19.74	-1.17 (-5.60%)	20.00	-0.91 (-4.35%)	6.75 - 43.56	1,559,754	497,898	8,784